Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 21, 2023, Kiora Pharmaceuticals, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the following proposals:
(i) the election of Kenneth Gayron, Aron Shapiro and Praveen Tyle, Ph.D. as Class II Directors, as nominated by the Company’s board of directors (the “Board”), for a three-year term, such term to continue until the annual meeting of stockholders in 2026 or until such directors’ successors are duly elected and qualified or until their earlier resignation or removal;
(ii) the approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers as disclosed in the definitive proxy statement filed with respect to the Annual Meeting; and
(iii) the ratification of the appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
The voting results are reported below.
Proposal 1 – Election of Directors
Kenneth Gayron, Aron Shapiro and Praveen Tyle, Ph.D. were elected as Class II Directors for a three-year term, such term to continue until the annual meeting of stockholders in 2026 and until such directors’ successors are duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows:
| | | | | | | | | | | | | | | | | | | | |
Name | | Votes For | | Votes Withheld | | Broker Non-Votes |
Kenneth Gayron | | 271,239 | | 24,844 | | 537,003 |
Aaron Shapiro | | 266,275 | | 29,808 | | 537,003 |
Praveen Tyle, Ph.D. | | 264,242 | | 31,841 | | 537,003 |
Proposal 2 - Approval, on a Non-Binding Basis, of the Compensation of the Company’s Executive Officers
The compensation of the Company’s executive officers as disclosed in the Company’s definitive proxy statement filed with respect to the Annual Meeting was approved on a non-binding basis. The results of the vote were as follows:
| | | | | | | | | | | | | | | | | | | | |
Votes For | | Votes Against | | Votes Abstained | | Broker Non-Votes |
243,595 | | 43,492 | | 8,996 | | 537,003 |
Proposal 3 - Ratification of the Appointment of Haskell & White LLP
The appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. There were no broker non-votes on this proposal. The results of the vote were as follows:
| | | | | | | | | | | | | | |
Votes For | | Votes Against | | Votes Abstained |
798,689 | | 14,659 | | 19,738 |